The CD226 Gly307Ser gene polymorphism is associated with severity of psoriasis

Journal of Dermatological Science

Volumn 58, Issue 2, 2010, Pages 160-161

  Douroudis, Konstantinos ^a   Kingo, Külli ^a   Silm, Helgi ^a   Reimann, Ene ^a   Traks, Tanel ^a   Vasar, Eero ^a   Kõks, Sulev ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

CD226 gene; Plaque type psoriasis; Polymorphism

Indexed keywords

CELL PROTEIN; CLUSTER OF DIFFERENTIATION 226 PROTEIN; GLYCINE; SERINE; UNCLASSIFIED DRUG;

ADULT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PSORIASIS; PSORIASIS SEVERITY INDEX; PSORIASIS VULGARIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE OF ONSET; ALLELES; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; AUTOIMMUNITY; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; GLYCINE; HUMANS; MALE; POLYMORPHISM, GENETIC; PSORIASIS; SERINE;

EID: 77952241926     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2010.03.015     Document Type: Letter

References (9)

1. Campalani E., Barker J.N.W.N. The clinical genetics of psoriasis. Curr Genomics 2005, 6:51-60.
2. Tiilikainen A., Lassus A., Karvonen J., Vartiainen P., Julin M. Psoriasis and HLA-Cw6. Br J Dermatol 1980, 102:179-184.
3. Trembath R.C., Clough R.L., Rosbotham J.L., Jones A.B., Camp R.D.R., Frodsham A., et al. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet 1997, 6:813-820.
4. Shibuya A., Campbell D., Hannum C., Yssel H., Franz-Bacon K., McClanahan T., et al. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 1996, 4:573-581.
5. Bottino C., Castriconi R., Pende D., Rivera P., Nanni M., Carnemolla B., et al. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. Exp Med 2003, 198:557-567.
6. Hafler J.P., Maier L.M., Cooper J.D., Plagnol V., Hinks A., Simmonds M.J., et al. CD226 Gly307Ser association with multiple autoimmune diseases. Genes Immun 2009, 10:5-10.
7. Wieczorek S., Hoffjan S., Chan A., Rey L., Harper L., Fricke H., et al. Novel association of the CD226 (DNAM-1) Gly307Ser polymorphism in Wegener's granulomatosis and confirmation for multiple sclerosis in German patients. Genes Immun 2009, 10:591-595.
8. Henseler T., Christophers E. Psoriasis of early and late onset: characterization of two types pf psoriasis vulgaris. J Am Acad Dermatol 1985, 13:450-456.
9. Fredriksson T., Petterson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978, 157:238-244.